Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018.

Shah MH, Goldner WS, Halfdanarson TR, Bergsland E, Berlin JD, Halperin D, Chan J, Kulke MH, Benson AB 3rd, Blaszkowsky LS, Eads J, Engstrom PF, Fanta P, Giordano T, He J, Heslin MJ, Kalemkerian GP, Kandeel F, Khan SA, Kidwai WZ, Kunz PL, Kuvshinoff BW 2nd, Lieu C, Pillarisetty VG, Saltz L, Sosa JA, Strosberg JR, Sussman CA, Trikalinos NA, Uboha NA, Whisenant J, Wong T, Yao JC, Burns JL, Ogba N, Zuccarino-Catania G.

J Natl Compr Canc Netw. 2018 Jun;16(6):693-702. doi: 10.6004/jnccn.2018.0056.

PMID:
29891520
2.

Adjuvant and Neoadjuvant Therapy for Resectable Pancreatic and Periampullary Cancer.

Kim SM, Eads JR.

Surg Clin North Am. 2016 Dec;96(6):1287-1300. doi: 10.1016/j.suc.2016.07.004. Review.

PMID:
27865278
3.

Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

Balaban EP, Mangu PB, Khorana AA, Shah MA, Mukherjee S, Crane CH, Javle MM, Eads JR, Allen P, Ko AH, Engebretson A, Herman JM, Strickler JH, Benson AB 3rd, Urba S, Yee NS.

J Clin Oncol. 2016 Aug 1;34(22):2654-68. doi: 10.1200/JCO.2016.67.5561. Epub 2016 May 31.

PMID:
27247216
4.

The role of neoadjuvant therapy in pancreatic cancer: a review.

Russo S, Ammori J, Eads J, Dorth J.

Future Oncol. 2016 Mar;12(5):669-85. doi: 10.2217/fon.15.335. Epub 2016 Feb 1. Review.

5.

A pharmacokinetic analysis of cisplatin and 5-fluorouracil in a patient with esophageal cancer on peritoneal dialysis.

Eads JR, Beumer JH, Negrea L, Holleran JL, Strychor S, Meropol NJ.

Cancer Chemother Pharmacol. 2016 Feb;77(2):333-8. doi: 10.1007/s00280-015-2939-9. Epub 2015 Dec 21.

6.

Poorly Differentiated Neuroendocrine Tumors.

Eads JR.

Hematol Oncol Clin North Am. 2016 Feb;30(1):151-62. doi: 10.1016/j.hoc.2015.09.007. Review.

PMID:
26614374
7.

Adjuvant and neoadjuvant options in resectable gastric cancer: is there an optimal treatment approach?

Chen X, Eads JR, Ammori JB, Kumar AM, Biswas T, Dorth JA.

Curr Oncol Rep. 2015 Apr;17(4):18. doi: 10.1007/s11912-015-0442-4. Review.

PMID:
25708803
8.

Update in hematology and oncology: evidence published in 2012.

Eads JR, Meropol NJ, Spivak JL.

Ann Intern Med. 2013 May 21;158(10):755-60. doi: 10.7326/0003-4819-158-10-201305210-00105. Review. No abstract available.

PMID:
23580059
9.

A new era for the systemic therapy of neuroendocrine tumors.

Eads JR, Meropol NJ.

Oncologist. 2012;17(3):326-38. doi: 10.1634/theoncologist.2011-0356. Epub 2012 Feb 21. Review.

Supplemental Content

Loading ...
Support Center